Oncological outcomes of screen-detected and non-screen-detected T1 colorectal cancers.
Lisa van der ScheeKrijn Jan Cornelis HaasnootSjoerd G EliasKim GijsbersY A AlderliesteYara BackesAnnemarie M van BerkelFemke BoersmaF Ter BorgEmilie C H BreekveldtKoen KesselsMiriam KoopmanIris Lansdorp-VogelaarMonique E van LeerdamGertjan RasschaertRamon Michel SchreuderR W M SchrauwenTom C J SeerdenMarcel B W SpanierJochim S Terhaar Sive DrosteEsther Toes-ZoutenkijkJurriaan TuynmanGeraldine R VinkWouter H de Vos Tot Nederveen CappelFrank P VleggaarM M LacleLeon Mg MoonsPublished in: Endoscopy (2024)
Screen-detected and non-screen-detected T1 CRCs have similar stage distributions and oncological outcomes and can therefore be treated equally. However, screen-detected T1 CRC patients exhibit a lower rate of non-CRC-related mortality, resulting in higher OS.